
Suchin Parihar
Examiner (ID: 2370, Phone: (571)272-6210 , Office: P/2851 )
| Most Active Art Unit | 2851 |
| Art Unit(s) | 2872, 2825, 2851 |
| Total Applications | 1402 |
| Issued Applications | 1184 |
| Pending Applications | 91 |
| Abandoned Applications | 151 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6735106
[patent_doc_number] => 20030012741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Process for the preparation of micronised collagen, and its therapeutic applications'
[patent_app_type] => new
[patent_app_number] => 10/169857
[patent_app_country] => US
[patent_app_date] => 2002-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1901
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20030012741.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169857
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169857 | Process for the preparation of micronised collagen, and its therapeutic applications | Jul 8, 2002 | Abandoned |
Array
(
[id] => 6817389
[patent_doc_number] => 20030068347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Use of microbially encapsulated meterials in cosmetic end formulations'
[patent_app_type] => new
[patent_app_number] => 10/169700
[patent_app_country] => US
[patent_app_date] => 2002-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6210
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20030068347.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169700
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169700 | Use of microbially encapsulated meterials in cosmetic end formulations | Jul 7, 2002 | Abandoned |
Array
(
[id] => 6778208
[patent_doc_number] => 20030049289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Cosmetic or dermatological preparations of the oil-in-water type'
[patent_app_type] => new
[patent_app_number] => 10/190075
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7588
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049289.pdf
[firstpage_image] =>[orig_patent_app_number] => 10190075
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/190075 | Cosmetic or dermatological preparations of the oil-in-water type | Jul 2, 2002 | Abandoned |
Array
(
[id] => 6705862
[patent_doc_number] => 20030152596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Cosmetic or dermatological composition comprising of a combination of an elastase inhibitor of the N-acylaminoamide family and at least one antifungal agent or at least one antibacterial agent'
[patent_app_type] => new
[patent_app_number] => 10/179983
[patent_app_country] => US
[patent_app_date] => 2002-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9062
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20030152596.pdf
[firstpage_image] =>[orig_patent_app_number] => 10179983
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/179983 | Cosmetic or dermatological composition comprising of a combination of an elastase inhibitor of the N-acylaminoamide family and at least one antifungal agent or at least one antibacterial agent | Jun 25, 2002 | Issued |
Array
(
[id] => 6842581
[patent_doc_number] => 20030147928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Antipruritic cosmetic and dermatological preparations'
[patent_app_type] => new
[patent_app_number] => 10/172241
[patent_app_country] => US
[patent_app_date] => 2002-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13065
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20030147928.pdf
[firstpage_image] =>[orig_patent_app_number] => 10172241
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/172241 | Antipruritic cosmetic and dermatological preparations | Jun 13, 2002 | Abandoned |
Array
(
[id] => 6716500
[patent_doc_number] => 20030027848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Stabilized formulations'
[patent_app_type] => new
[patent_app_number] => 10/171711
[patent_app_country] => US
[patent_app_date] => 2002-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2535
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20030027848.pdf
[firstpage_image] =>[orig_patent_app_number] => 10171711
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/171711 | Stabilized formulations | Jun 12, 2002 | Abandoned |
Array
(
[id] => 6715486
[patent_doc_number] => 20030026834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'NSAIDs composition containing tartaric acid'
[patent_app_type] => new
[patent_app_number] => 10/166050
[patent_app_country] => US
[patent_app_date] => 2002-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7795
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20030026834.pdf
[firstpage_image] =>[orig_patent_app_number] => 10166050
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/166050 | NSAIDs composition containing tartaric acid | Jun 10, 2002 | Abandoned |
Array
(
[id] => 6744633
[patent_doc_number] => 20030021816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes'
[patent_app_type] => new
[patent_app_number] => 10/167040
[patent_app_country] => US
[patent_app_date] => 2002-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3199
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20030021816.pdf
[firstpage_image] =>[orig_patent_app_number] => 10167040
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/167040 | Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes | Jun 5, 2002 | Abandoned |
Array
(
[id] => 6648530
[patent_doc_number] => 20030007931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => 'Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS)'
[patent_app_type] => new
[patent_app_number] => 10/160100
[patent_app_country] => US
[patent_app_date] => 2002-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3228
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0007/20030007931.pdf
[firstpage_image] =>[orig_patent_app_number] => 10160100
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/160100 | Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS) | Jun 3, 2002 | Issued |
Array
(
[id] => 6736051
[patent_doc_number] => 20030013686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Method of inhibiting restenosis using bisphosphonates'
[patent_app_type] => new
[patent_app_number] => 10/160207
[patent_app_country] => US
[patent_app_date] => 2002-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8870
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013686.pdf
[firstpage_image] =>[orig_patent_app_number] => 10160207
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/160207 | Method of inhibiting restenosis using bisphosphonates | May 29, 2002 | Issued |
Array
(
[id] => 6629191
[patent_doc_number] => 20030211149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Extended release tablets comprising felodipine'
[patent_app_type] => new
[patent_app_number] => 10/139347
[patent_app_country] => US
[patent_app_date] => 2002-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1647
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211149.pdf
[firstpage_image] =>[orig_patent_app_number] => 10139347
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/139347 | Extended release tablets comprising felodipine | May 6, 2002 | Abandoned |
Array
(
[id] => 6639540
[patent_doc_number] => 20030212046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs'
[patent_app_type] => new
[patent_app_number] => 10/140620
[patent_app_country] => US
[patent_app_date] => 2002-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3825
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212046.pdf
[firstpage_image] =>[orig_patent_app_number] => 10140620
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/140620 | Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs | May 6, 2002 | Abandoned |
Array
(
[id] => 6663701
[patent_doc_number] => 20030203027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Coating technique for deposition of drug substance on a substrate'
[patent_app_type] => new
[patent_app_number] => 10/134305
[patent_app_country] => US
[patent_app_date] => 2002-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6213
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203027.pdf
[firstpage_image] =>[orig_patent_app_number] => 10134305
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/134305 | Coating technique for deposition of drug substance on a substrate | Apr 25, 2002 | Abandoned |
Array
(
[id] => 6441705
[patent_doc_number] => 20020176833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-28
[patent_title] => 'Cosmetic composition'
[patent_app_type] => new
[patent_app_number] => 10/127475
[patent_app_country] => US
[patent_app_date] => 2002-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7209
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20020176833.pdf
[firstpage_image] =>[orig_patent_app_number] => 10127475
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/127475 | Cosmetic composition | Apr 22, 2002 | Abandoned |
Array
(
[id] => 6773869
[patent_doc_number] => 20030017207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Compositions and methods for treating vulvovaginitis and vaginosis'
[patent_app_type] => new
[patent_app_number] => 10/128611
[patent_app_country] => US
[patent_app_date] => 2002-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7065
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017207.pdf
[firstpage_image] =>[orig_patent_app_number] => 10128611
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/128611 | Compositions and methods for treating vulvovaginitis and vaginosis | Apr 22, 2002 | Abandoned |
Array
(
[id] => 790380
[patent_doc_number] => 06984400
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-01-10
[patent_title] => 'Method of treating restenosis using bisphosphonate nanoparticles'
[patent_app_type] => utility
[patent_app_number] => 10/126248
[patent_app_country] => US
[patent_app_date] => 2002-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 10488
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/984/06984400.pdf
[firstpage_image] =>[orig_patent_app_number] => 10126248
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/126248 | Method of treating restenosis using bisphosphonate nanoparticles | Apr 18, 2002 | Issued |
Array
(
[id] => 6110301
[patent_doc_number] => 20020172649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-21
[patent_title] => 'Pharmaceutical composition'
[patent_app_type] => new
[patent_app_number] => 10/124197
[patent_app_country] => US
[patent_app_date] => 2002-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3339
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20020172649.pdf
[firstpage_image] =>[orig_patent_app_number] => 10124197
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/124197 | Pharmaceutical composition | Apr 15, 2002 | Issued |
Array
(
[id] => 6715418
[patent_doc_number] => 20030026766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'Medicaments for treating respiratory disorders comprising formoterol and fluticasone'
[patent_app_type] => new
[patent_app_number] => 10/009956
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2983
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20030026766.pdf
[firstpage_image] =>[orig_patent_app_number] => 10009956
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/009956 | Medicaments for treating respiratory disorders comprising formoterol and fluticasone | Apr 11, 2002 | Abandoned |
Array
(
[id] => 6838455
[patent_doc_number] => 20030035795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-20
[patent_title] => 'Methods for treating or reducing the risk of pain and inflammatory disorders by administering inhibitors of activated thrombin activatable fibrinolysis inhibitor'
[patent_app_type] => new
[patent_app_number] => 10/120323
[patent_app_country] => US
[patent_app_date] => 2002-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10740
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20030035795.pdf
[firstpage_image] =>[orig_patent_app_number] => 10120323
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/120323 | Methods for treating or reducing the risk of pain and inflammatory disorders by administering inhibitors of activated thrombin activatable fibrinolysis inhibitor | Apr 10, 2002 | Abandoned |
Array
(
[id] => 6649042
[patent_doc_number] => 20030008003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-09
[patent_title] => 'Compositions for enhanced absorption of NSAIDs'
[patent_app_type] => new
[patent_app_number] => 10/119313
[patent_app_country] => US
[patent_app_date] => 2002-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7330
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20030008003.pdf
[firstpage_image] =>[orig_patent_app_number] => 10119313
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/119313 | Compositions for enhanced absorption of NSAIDs | Apr 9, 2002 | Abandoned |